Surgical Science Sweden AB
STO:SUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Surgical Science Sweden AB
STO:SUS
|
SE |
|
N
|
Nordique Resources Inc
CNSX:NORD
|
CA |
|
Dell Technologies Inc
NYSE:DELL
|
US |
|
A
|
Avalon Globocare Corp
NASDAQ:ALBT
|
US |
|
Great Panther Mining Ltd
TSX:GPR
|
CA |
|
Euro Sun Mining Inc
TSX:ESM
|
CA |
|
Avenir Telecom SA
PAR:AVT
|
FR |
|
Halcyon Agri Corporation Ltd
SGX:5VJ
|
SG |
|
E
|
Emimen Co Ltd
TSE:9237
|
JP |
|
Minerva SA
BOVESPA:BEEF3
|
BR |
|
Metalore Resources Ltd
XTSX:MET
|
CA |
Wall Street
Price Targets
SUS Price Targets Summary
Surgical Science Sweden AB
According to Wall Street analysts, the average 1-year price target for SUS is 63.24 SEK with a low forecast of 40.4 SEK and a high forecast of 92.4 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SUS's stock price target?
Price Target
63.24
SEK
According to Wall Street analysts, the average 1-year price target for SUS is 63.24 SEK with a low forecast of 40.4 SEK and a high forecast of 92.4 SEK.
What is Surgical Science Sweden AB's Revenue forecast?
Projected CAGR
10%
For the last 10 years the compound annual growth rate for Surgical Science Sweden AB's revenue is 36%. The projected CAGR for the next 3 years is 10%.
What is Surgical Science Sweden AB's Operating Income forecast?
Projected CAGR
63%
For the last 10 years the compound annual growth rate for Surgical Science Sweden AB's operating income is 44%. The projected CAGR for the next 3 years is 63%.
What is Surgical Science Sweden AB's Net Income forecast?
Projected CAGR
55%
For the last 10 years the compound annual growth rate for Surgical Science Sweden AB's net income is 45%. The projected CAGR for the next 3 years is 55%.
